{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T04:59:40Z","timestamp":1758862780792},"reference-count":51,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"published-print":{"date-parts":[[2020,1,1]]},"DOI":"10.1001\/jamaoncol.2019.4117","type":"journal-article","created":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T16:31:00Z","timestamp":1574353860000},"page":"133","source":"Crossref","is-referenced-by-count":12,"title":["Eligibility and Radiologic Assessment for Adjuvant Clinical Trials in Kidney Cancer"],"prefix":"10.1001","volume":"6","author":[{"given":"Sundeep","family":"Agrawal","sequence":"first","affiliation":[{"name":"Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomi B.","family":"Haas","sequence":"additional","affiliation":[{"name":"Abramson Cancer Center, Philadelphia, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammadhadi","family":"Bagheri","sequence":"additional","affiliation":[{"name":"Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian R.","family":"Lane","sequence":"additional","affiliation":[{"name":"Spectrum Health Cancer Center, Grand Rapids, Michigan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Coleman","sequence":"additional","affiliation":[{"name":"Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Hammers","sequence":"additional","affiliation":[{"name":"University of Texas Southwestern Medical Center, Dallas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gennady","family":"Bratslavsky","sequence":"additional","affiliation":[{"name":"Department of Urology, SUNY Upstate Medical University, Syracuse, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia","family":"Chauhan","sequence":"additional","affiliation":[{"name":"Heart Failure Society of America, Rockville, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren","family":"Kim","sequence":"additional","affiliation":[{"name":"Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Venkatesh P.","family":"Krishnasamy","sequence":"additional","affiliation":[{"name":"Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamie","family":"Marko","sequence":"additional","affiliation":[{"name":"Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia Ellen","family":"Maher","sequence":"additional","affiliation":[{"name":"Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amna","family":"Ibrahim","sequence":"additional","affiliation":[{"name":"Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Frank","family":"Cross","sequence":"additional","affiliation":[{"name":"Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Liu","sequence":"additional","affiliation":[{"name":"Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia A.","family":"Beaver","sequence":"additional","affiliation":[{"name":"Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Pazdur","sequence":"additional","affiliation":[{"name":"Oncology Center of Excellence, Food and Drug Administration, Silver Spring, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gideon M.","family":"Blumenthal","sequence":"additional","affiliation":[{"name":"Oncology Center of Excellence, Food and Drug Administration, Silver Spring, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harpreet","family":"Singh","sequence":"additional","affiliation":[{"name":"Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth R.","family":"Plimack","sequence":"additional","affiliation":[{"name":"Fox Chase Cancer Center, Philadelphia, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toni K.","family":"Choueiri","sequence":"additional","affiliation":[{"name":"Dana-Farber Cancer Institute, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Uzzo","sequence":"additional","affiliation":[{"name":"Fox Chase Cancer Center, Philadelphia, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea B.","family":"Apolo","sequence":"additional","affiliation":[{"name":"Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"key":"csc190002r1","article-title":"Eligibility and radiologic assessment in adjuvant clinical trials in bladder cancer","author":"Apolo","journal-title":"JAMA Oncol"},{"issue":"4","key":"csc190002r2","doi-asserted-by":"publisher","first-page":"727","DOI":"10.2214\/AJR.14.12921","article-title":"Lung nodule detection by microdose CT versus chest radiography (standard and dual-energy subtracted).","volume":"204","author":"Ebner","year":"2015","journal-title":"AJR Am J Roentgenol"},{"key":"csc190002r3","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jss.2017.02.070","article-title":"Surveillance strategies in the follow-up of melanoma patients: too much or not enough?","volume":"214","author":"Kurtz","year":"2017","journal-title":"J Surg Res"},{"issue":"1","key":"csc190002r4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2214\/ajr.166.1.8571866","article-title":"Detection and differential diagnosis of pulmonary infections and tumors in patients with AIDS: value of chest radiography versus CT.","volume":"166","author":"Kang","year":"1996","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"csc190002r6","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.eururo.2016.02.029","article-title":"The 2016 WHO classification of tumours of the urinary system and male genital organs\u2014part A: renal, penile, and testicular tumours.","volume":"70","author":"Moch","year":"2016","journal-title":"Eur Urol"},{"issue":"4","key":"csc190002r7","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1053\/j.seminoncol.2013.05.009","article-title":"Non-clear cell renal cancer: disease-based management and opportunities for targeted therapeutic approaches.","volume":"40","author":"Linehan","year":"2013","journal-title":"Semin Oncol"},{"issue":"5","key":"csc190002r8","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/path.2018.244.issue-5","article-title":"Genomic classifications of renal cell carcinoma: a critical step towards the future application of personalized kidney cancer care with pan-omics precision.","volume":"244","author":"Hsieh","year":"2018","journal-title":"J Pathol"},{"issue":"7","key":"csc190002r9","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1001\/jamaoncol.2016.4419","article-title":"Adjuvant weekly girentuximab following nephrectomy for high-risk renal cell carcinoma: the ARISER randomized clinical trial.","volume":"3","author":"Chamie","year":"2017","journal-title":"JAMA Oncol"},{"issue":"10032","key":"csc190002r10","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1016\/S0140-6736(16)00559-6","article-title":"Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial.","volume":"387","author":"Haas","year":"2016","journal-title":"Lancet"},{"issue":"23","key":"csc190002r11","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1056\/NEJMoa1611406","article-title":"Adjuvant sunitinib in high-risk renal-cell carcinoma after nephrectomy.","volume":"375","author":"Ravaud","year":"2016","journal-title":"N Engl J Med"},{"issue":"1","key":"csc190002r12","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.eururo.2017.09.008","article-title":"Adjuvant sunitinib for high-risk renal cell carcinoma after nephrectomy: subgroup analyses and updated overall survival results.","volume":"73","author":"Motzer","year":"2018","journal-title":"Eur Urol"},{"issue":"35","key":"csc190002r13","doi-asserted-by":"publisher","first-page":"3916","DOI":"10.1200\/JCO.2017.73.5324","article-title":"Randomized phase III trial of adjuvant pazopanib versus placebo after nephrectomy in patients with localized or locally advanced renal cell carcinoma.","volume":"35","author":"Motzer","year":"2017","journal-title":"J Clin Oncol"},{"issue":"23","key":"csc190002r14","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1200\/JCO.19.00107","article-title":"Predicting renal cancer recurrence: defining limitations of existing prognostic models with prospective trial-based validation.","volume":"37","author":"Correa","year":"2019","journal-title":"J Clin Oncol"},{"issue":"4","key":"csc190002r15","doi-asserted-by":"publisher","first-page":"e379","DOI":"10.1016\/j.clgc.2016.01.012","article-title":"Local recurrence after curative surgical treatment of renal cell cancer: a study of 91 patients.","volume":"14","author":"Du","year":"2016","journal-title":"Clin Genitourin Cancer"},{"issue":"6","key":"csc190002r16","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1097\/01.ju.0000158043.94525.d6","article-title":"Independent validation of the 2002 American Joint Committee on cancer primary tumor classification for renal cell carcinoma using a large, single institution cohort.","volume":"173","author":"Frank","year":"2005","journal-title":"J Urol"},{"issue":"2","key":"csc190002r17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s11934-017-0661-3","article-title":"Recurrence in localized renal cell carcinoma: a systematic review of contemporary data.","volume":"18","author":"Speed","year":"2017","journal-title":"Curr Urol Rep"},{"issue":"2","key":"csc190002r18","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.juro.2010.09.100","article-title":"Clinical characteristics and outcomes of patients with recurrence 5 years after nephrectomy for localized renal cell carcinoma.","volume":"185","author":"Adamy","year":"2011","journal-title":"J Urol"},{"issue":"4","key":"csc190002r19","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.urology.2010.11.050","article-title":"Prevalence of baseline chronic kidney disease in patients presenting with solid renal tumors.","volume":"77","author":"Canter","year":"2011","journal-title":"Urology"},{"issue":"13","key":"csc190002r20","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"issue":"13","key":"csc190002r22","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1056\/NEJMoa1713709","article-title":"Duration of adjuvant chemotherapy for stage III colon cancer.","volume":"378","author":"Grothey","year":"2018","journal-title":"N Engl J Med"},{"issue":"1","key":"csc190002r23","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/bju.2005.96.issue-1","article-title":"Surgical treatment of stage pT3b renal cell carcinoma in solitary kidneys: a case series.","volume":"96","author":"Sengupta","year":"2005","journal-title":"BJU Int"},{"issue":"3","key":"csc190002r24","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.urology.2009.10.073","article-title":"Single institutional experience with nephron-sparing surgery for pathologic stage T3bNxM0 renal cell carcinoma confined to the renal vein.","volume":"76","author":"Woldu","year":"2010","journal-title":"Urology"},{"issue":"9","key":"csc190002r25","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1111\/bju.2012.109.issue-9","article-title":"Partial nephrectomy in two patients with known T3a tumours involving the renal vein.","volume":"109","author":"Kim","year":"2012","journal-title":"BJU Int"},{"issue":"10","key":"csc190002r26","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1111\/j.1464-410X.2010.09293.x","article-title":"Nephron-sparing surgery for pathological stage T3b renal cell carcinoma confined to the renal vein.","volume":"106","author":"Kolla","year":"2010","journal-title":"BJU Int"},{"issue":"6","key":"csc190002r27","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1016\/j.urology.2013.01.052","article-title":"Robotic partial nephrectomy for renal cell carcinomas with venous tumor thrombus.","volume":"81","author":"Abaza","year":"2013","journal-title":"Urology"},{"issue":"1","key":"csc190002r28","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.eururo.2008.09.052","article-title":"Radical nephrectomy with and without lymph-node dissection: final results of European Organization for Research and Treatment of Cancer (EORTC) randomized phase 3 trial 30881.","volume":"55","author":"Blom","year":"2009","journal-title":"Eur Urol"},{"issue":"1","key":"csc190002r29","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.juro.2017.07.042","article-title":"Retroperitoneal lymphadenectomy for high risk, nonmetastatic renal cell carcinoma: an analysis of the ASSURE (ECOG-ACRIN 2805) adjuvant trial.","volume":"199","author":"Ristau","year":"2018","journal-title":"J Urol"},{"issue":"10","key":"csc190002r30","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1007\/s00270-017-1658-5","article-title":"CIRSE guidelines on percutaneous needle biopsy (PNB).","volume":"40","author":"Veltri","year":"2017","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"5","key":"csc190002r32","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.jvir.2012.12.007","article-title":"Addendum of newer anticoagulants to the SIR consensus guideline.","volume":"24","author":"Patel","year":"2013","journal-title":"J Vasc Interv Radiol"},{"issue":"6","key":"csc190002r33","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.jvir.2012.02.012","article-title":"Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions.","volume":"23","author":"Patel","year":"2012","journal-title":"J Vasc Interv Radiol"},{"issue":"4","key":"csc190002r34","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1055\/s-00000068","article-title":"Navigational tools for interventional radiology and interventional oncology applications.","volume":"32","author":"Chehab","year":"2015","journal-title":"Semin Intervent Radiol"},{"issue":"2","key":"csc190002r35","doi-asserted-by":"publisher","first-page":"413","DOI":"10.2214\/AJR.07.2676","article-title":"Percutaneous imaging-guided solid organ core needle biopsy: coaxial versus noncoaxial method.","volume":"190","author":"Hatfield","year":"2008","journal-title":"AJR Am J Roentgenol"},{"issue":"10","key":"csc190002r36","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1016\/j.jvir.2018.03.028","article-title":"CT-guided percutaneous needle biopsy of retroperitoneal and pelvic lymphadenopathy: assessment of technique, diagnostic yield, and clinical value.","volume":"29","author":"Shao","year":"2018","journal-title":"J Vasc Interv Radiol"},{"issue":"5","key":"csc190002r37","doi-asserted-by":"publisher","first-page":"964","DOI":"10.2214\/AJR.12.10156","article-title":"Percutaneous CT-guided aspiration and core biopsy of pulmonary nodules smaller than 1 cm: analysis of outcomes of 305 procedures from a tertiary referral center.","volume":"201","author":"Choi","year":"2013","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"csc190002r38","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"csc190002r39","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ejrad.2017.10.019","article-title":"Lower tract neoplasm: update of imaging evaluation.","volume":"97","author":"Hartman","year":"2017","journal-title":"Eur J Radiol"},{"issue":"1","key":"csc190002r40","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1148\/radiol.2541090361","article-title":"Lymphatic metastases from pelvic tumors: anatomic classification, characterization, and staging.","volume":"254","author":"McMahon","year":"2010","journal-title":"Radiology"},{"issue":"4","key":"csc190002r41","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1093\/annonc\/mdr362","article-title":"Distribution of metastatic sites in renal cell carcinoma: a population-based analysis.","volume":"23","author":"Bianchi","year":"2012","journal-title":"Ann Oncol"},{"issue":"6","key":"csc190002r42","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/S0022-5347(17)54243-3","article-title":"Distant metastasis of renal adenocarcinoma in nephrectomized cases.","volume":"127","author":"Saitoh","year":"1982","journal-title":"J Urol"},{"issue":"3","key":"csc190002r43","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.juro.2014.09.020","article-title":"Subcentimeter pulmonary nodules are not associated with disease progression in patients with renal cell carcinoma.","volume":"193","author":"Mano","year":"2015","journal-title":"J Urol"},{"issue":"2","key":"csc190002r44","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1148\/radiol.2372041887","article-title":"Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society.","volume":"237","author":"MacMahon","year":"2005","journal-title":"Radiology"},{"issue":"1","key":"csc190002r45","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1148\/radiol.2017161659","article-title":"Guidelines for management of incidental pulmonary nodules detected on CT images: from the Fleischner Society 2017.","volume":"284","author":"MacMahon","year":"2017","journal-title":"Radiology"},{"issue":"6","key":"csc190002r46","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1148\/rg.336125110","article-title":"Metastatic renal cell carcinoma: radiologic findings and assessment of response to targeted antiangiogenic therapy by using multidetector CT.","volume":"33","author":"Brufau","year":"2013","journal-title":"RadioGraphics"},{"issue":"3","key":"csc190002r47","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1097\/00004728-199105000-00019","article-title":"Renal cell carcinoma presenting with diffuse peritoneal metastases: CT findings.","volume":"15","author":"Tartar","year":"1991","journal-title":"J Comput Assist Tomogr"},{"issue":"3","key":"csc190002r48","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/S0022-5347(01)61805-6","article-title":"An unusual renal mass after partial nephrectomy for renal cell carcinoma.","volume":"161","author":"Jones","year":"1999","journal-title":"J Urol"},{"issue":"11","key":"csc190002r49","doi-asserted-by":"publisher","first-page":"436","DOI":"10.4329\/wjr.v5.i11.436","article-title":"MDCT imaging following nephrectomy for renal cell carcinoma: protocol optimization and patterns of tumor recurrence.","volume":"5","author":"Coquia","year":"2013","journal-title":"World J Radiol"},{"issue":"7","key":"csc190002r51","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1200\/JCO.1989.7.7.969","article-title":"Analyzing the same data in two ways: a demonstration model to illustrate the reporting and misreporting of clinical trials.","volume":"7","author":"Baar","year":"1989","journal-title":"J Clin Oncol"},{"key":"csc190002r50","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1007\/0-306-47678-9","volume-title":"TxNxM1: The Anatomy and Clinics of Metastatic Cancer","author":"Debois","year":"2002"},{"key":"csc190002r5","unstructured":"Quantitative Imaging Biomarkers Alliance. QIBA CT Volumetry Technical Committee. CT tumor volume change profile \u2013 2018. Technically Confirmed Profile. http:\/\/qibawiki.rsna.org\/index.php\/Profiles. Accessed October 21, 2019."},{"key":"csc190002r21","unstructured":"American College of Surgeons. ACS National Surgical Quality Improvement Program. https:\/\/www.facs.org\/quality-programs\/acs-nsqip. Accessed October 21, 2019."},{"key":"csc190002r31","unstructured":"American College of Radiology (ACR), the Society of Interventional Radiology (SIR), and the Society for Pediatric Radiology (SPR). ACR\u2013SIR\u2013SPR practice parameter for the performance of percutaneous nephrostomy. https:\/\/www.acr.org\/-\/media\/ACR\/Files\/Practice-Parameters\/percutaneous-nephros.pdf. Revised 2016. Accessed September 4, 2019."}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/articlepdf\/2755432\/jamaoncology_agrawal_2019_sc_190002.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T06:24:17Z","timestamp":1695450257000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2755432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,1]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2019.4117","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1,1]]}}}